Altria Reports Q3 and 9-Month Operating Performance 2022

Nov.02.2022
Altria Reports Q3 and 9-Month Operating Performance 2022
Altria reported Q3 and 9-month results, narrowing their full-year EPS guidance and highlighting investments in non-smoking categories.

Altria Group has released its operational results for the third quarter and 9 months of 2022, and has revised its guidance for adjusted diluted earnings per share (EPS) for the full year of 2022.


Billy Gifford, CEO of Altria, stated in a press release that this is an exciting moment for the company as it moves towards its goal of going beyond smoking. Despite challenges in the tobacco industry in the first nine months of this year, Altria remained strong and rewarded its shareholders while investing in achieving its vision.


Altria's net profit dropped by 3.5 percent in the third quarter. The company's management remains optimistic, stating that their strategic actions have strengthened their product portfolio within the three major smokeless product categories. Altria has established an impressive selection of heated tobacco products and enhanced their competitiveness in the e-cigarette market, while further solidifying their position in the industry.


We are narrowing the guidance range for the full year of 2022, and the adjusted diluted earnings per share are expected to be within the range of $4.81 to $4.89. This represents a growth of 4.5% to 6% from the base of $4.61 in 2021. We believe that this range allows us to be flexible in responding to market conditions.


Net income for the third quarter decreased by 3.5% to 6.6 billion US dollars, due to a decline in net income for both the Michel wine business and the combustible products sector, partially offset by higher net income from the electronic cigarette sector. Revenue, after deducting sales taxes, decreased by 2.2%, to 5.4 billion US dollars.


The report shows a 100% increase in diluted earnings per share, reaching $0.12, mainly due to reduced losses reported by ABI investments (primarily due to a decrease in the company's impairment of ABI investments), favorable Cronos-related special projects, increased operating company income (OCI), and a decrease in outstanding shares, partially offset by adverse changes in the estimated fair value of the company's investment in Juul (including corresponding tax valuation allowances adjustments). Adjusted diluted earnings per share increased by 4.9% to $1.28, mainly due to increased adjusted other comprehensive income and a decrease in outstanding shares.


The company's net income for the first three quarters of the year decreased by 3.9%, to $19 billion, primarily due to the sale of its stake in Michelle Wine Estates and a decline in net income from its tobacco products sector. Revenue, excluding consumption tax, decreased by 2.6% to $15.6 billion.


Statement:


This article is compiled from third-party information and intended solely for industry exchange and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry exchange and research.


Due to the limitations of our translation skills, the translated article may not fully reflect the original text. Please refer to the original version for accurate information.


In regards to any domestic, Hong Kong, Macau, Taiwan, or international issues, 2FIRSTS is aligned with the position and statements of the Chinese government.


The copyright of the compiled information belongs to the original media and author. If there is an infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan announced the launch of a new TEREA heated tobacco stick for the IQOS ILUMA series, “TEREA Stellar Pearl,” featuring a crushable capsule mint profile. The product will go on sale in Japan through offline retail channels from Jan. 19 and will be rolled out on the company’s official e-commerce store from Jan. 29, priced at 580 yen (about $3.6) per pack.
Jan.14 by 2FIRSTS.ai
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia’s HB 308 (Substitute) proposes a sweeping rewrite of how tobacco, nicotine and certain smokable hemp products are regulated, consolidating enforcement under ABC, requiring retailer permits, creating a vape product directory and escalating penalties for violations.
Feb.06 by 2FIRSTS.ai
Scottish retailers call for tougher action as illegal vape black market “deepens,” SGF says
Scottish retailers call for tougher action as illegal vape black market “deepens,” SGF says
Scottish retailers, through the Scottish Grocers’ Federation (SGF), are calling for tougher action and more investment to tackle a “deepening black market” in illegal vapes, including illegal sales to children. SGF warns the problem will worsen, with negative health impacts, if incoming regulations on vaping product sales are not carefully crafted and if shopkeepers’ views are not heard.
Jan.14 by 2FIRSTS.ai
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea launches TEREA “Shine Pearl” for IQOS ILUMA, expands capsule range to seven variants
Philip Morris Korea said on Feb. 5 it has introduced “TEREA Shine Pearl,” a new TEREA stick designed for the IQOS ILUMA heated-tobacco device. The company said the product delivers a cool sensation and adds a fresh, fruity note when the capsule is crushed, bringing TEREA’s capsule-based lineup in South Korea to seven variants.
Feb.05 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai